Literature DB >> 17560271

DNA deamination in immunity: AID in the context of its APOBEC relatives.

Silvestro G Conticello1, Marc-Andre Langlois, Zizhen Yang, Michael S Neuberger.   

Abstract

The activation-induced cytidine deaminase (AID)/apolipoprotein B RNA-editing catalytic component (APOBEC) family is a vertebrate-restricted subgrouping of a superfamily of zinc (Zn)-dependent deaminases that has members distributed throughout the biological world. AID and APOBEC2 are the oldest family members with APOBEC1 and the APOBEC3s being later arrivals restricted to placental mammals. Many AID/APOBEC family members exhibit cytidine deaminase activity on polynucleotides, although in different physiological contexts. Here, we examine the AID/APOBEC proteins in the context of the entire Zn-dependent deaminase superfamily. On the basis of secondary structure predictions, we propose that the cytosine and tRNA deaminases are likely to provide better structural paradigms for the AID/APOBEC family than do the cytidine deaminases, to which they have conventionally been compared. These comparisons yield predictions concerning likely polynucleotide-interacting residues in AID/APOBEC3s, predictions that are supported by mutagenesis studies. We also focus on a specific comparison between AID and the APOBEC3s. Both are DNA deaminases that function in immunity and are responsible for the hypermutation of their target substrates. AID functions in the adaptive immune system to diversify antibodies with targeted DNA deamination being central to this function. APOBEC3s function as part of an innate pathway of immunity to retroviruses with targeted DNA deamination being central to their activity in retroviral hypermutation. However, the mechanism by which the APOBEC3s fulfill their function of retroviral restriction remains unresolved.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560271     DOI: 10.1016/S0065-2776(06)94002-4

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  85 in total

1.  Association of potent human antiviral cytidine deaminases with 7SL RNA and viral RNP in HIV-1 virions.

Authors:  Wenyan Zhang; Juan Du; Kevin Yu; Tao Wang; Xiong Yong; Xiao-Fang Yu
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Large-scale DNA editing of retrotransposons accelerates mammalian genome evolution.

Authors:  Shai Carmi; George M Church; Erez Y Levanon
Journal:  Nat Commun       Date:  2011-11-01       Impact factor: 14.919

3.  APOBEC3 proteins and genomic stability: the high cost of a good defense.

Authors:  Iñigo Narvaiza; Sébastien Landry; Matthew D Weitzman
Journal:  Cell Cycle       Date:  2012-01-01       Impact factor: 4.534

4.  Evolution and immunity.

Authors:  Jim Kaufman
Journal:  Immunology       Date:  2010-05-11       Impact factor: 7.397

Review 5.  When you can't trust the DNA: RNA editing changes transcript sequences.

Authors:  Volker Knoop
Journal:  Cell Mol Life Sci       Date:  2010-10-12       Impact factor: 9.261

6.  Strand-biased cytosine deamination at the replication fork causes cytosine to thymine mutations in Escherichia coli.

Authors:  Ashok S Bhagwat; Weilong Hao; Jesse P Townes; Heewook Lee; Haixu Tang; Patricia L Foster
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-02       Impact factor: 11.205

7.  Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain.

Authors:  Junjie U Guo; Yijing Su; Chun Zhong; Guo-li Ming; Hongjun Song
Journal:  Cell       Date:  2011-04-14       Impact factor: 41.582

Review 8.  Reprogramming mRNA translation during stress.

Authors:  Satoshi Yamasaki; Paul Anderson
Journal:  Curr Opin Cell Biol       Date:  2008-03-20       Impact factor: 8.382

9.  One problem, two solutions.

Authors:  Thomas Boehm
Journal:  Nat Immunol       Date:  2009-08       Impact factor: 25.606

Review 10.  The current structural and functional understanding of APOBEC deaminases.

Authors:  Ronda Bransteitter; Courtney Prochnow; Xiaojiang S Chen
Journal:  Cell Mol Life Sci       Date:  2009-06-23       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.